IRCT20200430047250N1招募中2 期
A comparative study of the effectiveness and safety of Aripiprazole and Olanzapine in patients with psychotic disorders; A clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 94
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 64 years（—）
- 性别
- All
入选标准
- •Diagnosing psychotic disorders through clinical interview and DSM-5 & ICSD-III criteria
- •Prescribing Aripiprazole or Olanzapine as a treatment strategy for psychotic disorders
- •Patients aged 18-64 years
排除标准
- •Patients simultaneously taking medications such as sleeping pills and Aripiprazole or Olanzapine (drugs that have high sedative effects)
- •Patients suffering dependence on or abuse of Aripiprazole or Olanzapine
- •Patients with multiple chronic physical illnesses such as Diabetes, High Blood Pressure, and Rheumatism
- •Patients with certain health conditions( preventing them form taking Aripiprazole or Olanzapine )
研究者
相似试验
招募中
3 期
The comparison of two regimens of diphencyprone in alopecia areata patients.Alopecia areataalopecia areata.IRCT20141209020250N5Tehran University of Medical Sciences60
尚未招募
Unknown
A Comparative Study on the Effectiveness and Safety of Thread Embedding Acupuncture(TEA) and Acupuncture in Patients with Knee Osteoarthritis : A Pilot, Assessor-blinded, Randomized, Controlled TrialDiseases of the musculoskeletal system and connective tissueKCT0008979Daejeon Korean Medicine Hospital of Daejeon University60
进行中（未招募）
1 期
A STUDY TO COMPARE HOW SAFE DAPTOMYCIN IS VERSUS OTHER DRUGS IN CHILDREN AGED TWO TO SEVENTEEN WHO HAVE INFECTIONS CAUSED BY THE STAPHYLOCOCCUS AUREUS BACTERIA.Bacteremia caused by Staphylococcus Aureus.MedDRA version: 14.1 Level: LLT Classification code 10054637 Term: Staphylococcal bacteremia System Organ Class: 100000004862EUCTR2012-003447-29-ITCubist Pharmaceuticals, Inc.82
进行中（未招募）
1 期
A COMPARATIVE EVALUATION OF THE SAFETY AND EFFICACY OF DAPTOMYCIN VERSUS STANDARD OF CARE IN PEDIATRIC SUBJECTS TWO - SEVENTEEN YEARS OF AGE WITH BACTEREMIA CAUSED BY STAPHYLOCOCCUS AUREUS.Bacteremia caused by Staphylococcus Aureus.MedDRA version: 16.0 Level: LLT Classification code 10054637 Term: Staphylococcal bacteremia System Organ Class: 100000004862EUCTR2012-003447-29-GRCubist Pharmaceuticals, Inc.82
进行中（未招募）
1 期
A STUDY TO COMPARE HOW SAFE DAPTOMYCIN IS VERSUS OTHER DRUGS IN CHILDREN AGED TWO TO SEVENTEEN WHO HAVE INFECTIONS CAUSED BY THE STAPHYLOCOCCUS AUREUS BACTERIA.Bacteremia caused by Staphylococcus Aureus.MedDRA version: 14.1Level: LLTClassification code 10054637Term: Staphylococcal bacteremiaSystem Organ Class: 100000004862EUCTR2012-003447-29-ESCubist Pharmaceuticals, Inc.75